These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 20971655)

  • 1. Silent infarction or white matter hyperintensity and impaired attention task scores in a nondemented population: the Osaki-Tajiri Project.
    Ishikawa H; Meguro K; Ishii H; Tanaka N; Yamaguchi S
    J Stroke Cerebrovasc Dis; 2012 May; 21(4):275-82. PubMed ID: 20971655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between white matter hyperintensity and lacunar infarction on MRI and subitem scores of the Japanese version of mini-mental state examination for testing cognitive decline: the Ohasama study.
    Elnimr EM; Kondo T; Suzukamo Y; Satoh M; Oouchida Y; Hara A; Ohkubo T; Kikuya M; Hirano M; Hosokawa A; Hosokawa T; Imai Y; Izumi S
    Clin Exp Hypertens; 2012; 34(8):541-7. PubMed ID: 22564143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of ischemic cholinergic damage on cognition in patients with subcortical vascular cognitive impairment.
    Kim SH; Kang HS; Kim HJ; Moon Y; Ryu HJ; Kim MY; Han SH
    J Geriatr Psychiatry Neurol; 2012 Jun; 25(2):122-7. PubMed ID: 22689705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subcortical white matter hyperintensities within the cholinergic pathways of Parkinson's disease patients according to cognitive status.
    Shin J; Choi S; Lee JE; Lee HS; Sohn YH; Lee PH
    J Neurol Neurosurg Psychiatry; 2012 Mar; 83(3):315-21. PubMed ID: 22228726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The burden of white matter hyperintensities is a predictor of progressive mild cognitive impairment in patients with Parkinson's disease.
    Sunwoo MK; Jeon S; Ham JH; Hong JY; Lee JE; Lee JM; Sohn YH; Lee PH
    Eur J Neurol; 2014 Jun; 21(6):922-e50. PubMed ID: 24661277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Small vessel disease and general cognitive function in nondisabled elderly: the LADIS study.
    van der Flier WM; van Straaten EC; Barkhof F; Verdelho A; Madureira S; Pantoni L; Inzitari D; Erkinjuntti T; Crisby M; Waldemar G; Schmidt R; Fazekas F; Scheltens P
    Stroke; 2005 Oct; 36(10):2116-20. PubMed ID: 16141425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of cholinergic pathway disruption on cortical and subcortical volumes in subcortical vascular cognitive impairment.
    Lim JS; Kwon HM; Lee YS
    Eur J Neurol; 2020 Jan; 27(1):210-212. PubMed ID: 31444924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebral MRI findings and cognitive functioning: the Atherosclerosis Risk in Communities study.
    Mosley TH; Knopman DS; Catellier DJ; Bryan N; Hutchinson RG; Grothues CA; Folsom AR; Cooper LS; Burke GL; Liao D; Szklo M
    Neurology; 2005 Jun; 64(12):2056-62. PubMed ID: 15985571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. White matter hyperintensities and cognitive impairment during electroconvulsive therapy in severely depressed elderly patients.
    Oudega ML; van Exel E; Wattjes MP; Comijs HC; Scheltens P; Barkhof F; Eikelenboom P; de Craen AJ; Beekman AT; Stek ML
    Am J Geriatr Psychiatry; 2014 Feb; 22(2):157-66. PubMed ID: 23567440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential cholinergic pathway involvement in Alzheimer's disease and subcortical ischemic vascular dementia.
    Kim HJ; Moon WJ; Han SH
    J Alzheimers Dis; 2013; 35(1):129-36. PubMed ID: 23364137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progression of white matter hyperintensities and incidence of new lacunes over a 3-year period: the Leukoaraiosis and Disability study.
    Gouw AA; van der Flier WM; Fazekas F; van Straaten EC; Pantoni L; Poggesi A; Inzitari D; Erkinjuntti T; Wahlund LO; Waldemar G; Schmidt R; Scheltens P; Barkhof F;
    Stroke; 2008 May; 39(5):1414-20. PubMed ID: 18323505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive dysfunction associates with white matter hyperintensities and subcortical atrophy on magnetic resonance imaging of the elderly diabetes mellitus Japanese elderly diabetes intervention trial (J-EDIT).
    Akisaki T; Sakurai T; Takata T; Umegaki H; Araki A; Mizuno S; Tanaka S; Ohashi Y; Iguchi A; Yokono K; Ito H
    Diabetes Metab Res Rev; 2006; 22(5):376-84. PubMed ID: 16506272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diabetes, Brain Infarcts, Cognition, and Small Vessels in the Canadian Alliance for Healthy Hearts and Minds Study.
    Gerstein HC; Smith EE; Ramasundarahettige C; Desai D; Awadalla P; Broet P; Black S; Dummer TJB; Hicks J; Moody A; Tardif JC; Teo KK; Vena J; Yusuf S; Lee DS; Friedrich MG; Anand SS
    J Clin Endocrinol Metab; 2021 Jan; 106(2):e891-e898. PubMed ID: 33165530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic syndrome is associated with silent ischemic brain lesions.
    Bokura H; Yamaguchi S; Iijima K; Nagai A; Oguro H
    Stroke; 2008 May; 39(5):1607-9. PubMed ID: 18323475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of periventricular hyperintensities and cystatin C on different cognitive domains in the population of non-demented elderly Chinese.
    Zhang S; Luo Y; Dong Z; Chen X; Cheng X; Dong Q; Wu D
    J Clin Neurosci; 2019 Oct; 68():201-210. PubMed ID: 31307855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. White matter hyperintensities in cholinergic pathways correlates of cognitive impairment in moyamoya disease.
    Xu D; Yu X; Hu J; Yu Y; Wang L; Jiang B; Zhang M
    Eur Radiol; 2024 Jul; 34(7):4596-4606. PubMed ID: 38092950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of medial temporal atrophy and white matter hyperintensities on the cognitive functions in patients with Alzheimer's disease.
    Shim YS; Youn YC; Na DL; Kim SY; Cheong HK; Moon SY; Park KW; Ku BD; Lee JY; Jeong JH; Kang H; Kim EJ; Lee JS; Go SM; Kim SH; Cha KR; Seo SW
    Eur Neurol; 2011; 66(2):75-82. PubMed ID: 21778730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuropathological basis of magnetic resonance images in aging and dementia.
    Jagust WJ; Zheng L; Harvey DJ; Mack WJ; Vinters HV; Weiner MW; Ellis WG; Zarow C; Mungas D; Reed BR; Kramer JH; Schuff N; DeCarli C; Chui HC
    Ann Neurol; 2008 Jan; 63(1):72-80. PubMed ID: 18157909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. White Matter Hyperintensities in Mild Cognitive Impairment and Lower Risk of Cognitive Decline.
    Nolze-Charron G; Mouiha A; Duchesne S; Bocti C;
    J Alzheimers Dis; 2015; 46(4):855-62. PubMed ID: 26402625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation between images of silent brain infarction, carotid atherosclerosis and white matter hyperintensity, and plasma levels of acrolein, IL-6 and CRP.
    Yoshida M; Higashi K; Kobayashi E; Saeki N; Wakui K; Kusaka T; Takizawa H; Kashiwado K; Suzuki N; Fukuda K; Nakamura T; Watanabe S; Tada K; Machi Y; Mizoi M; Toida T; Kanzaki T; Tomitori H; Kashiwagi K; Igarashi K
    Atherosclerosis; 2010 Aug; 211(2):475-9. PubMed ID: 20417516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.